PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15 | -25.0% | 679 | +26.0% | 0.00% | – |
Q4 2022 | $20 | -100.0% | 539 | -60.4% | 0.00% | – |
Q3 2022 | $68,000 | +9.7% | 1,361 | -7.0% | 0.00% | – |
Q2 2021 | $62,000 | -24.4% | 1,464 | -39.9% | 0.00% | – |
Q2 2018 | $82,000 | -81.4% | 2,437 | -85.0% | 0.00% | -100.0% |
Q1 2018 | $440,000 | +86.4% | 16,232 | +38.0% | 0.00% | +100.0% |
Q3 2017 | $236,000 | -14.8% | 11,762 | -53.7% | 0.00% | 0.0% |
Q4 2016 | $277,000 | – | 25,421 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |